Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 12.37 0.00%
ENTA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $360.28M
- EPS (TTM)
- -$2.42
- Dividend yield
- None
- 52-week range
- 10.20 – 17.15
- Day range
- 12.08 – 12.57
- Volume / Avg
- 167.42K / 226.69K
- Beta
- —
- Shares outstanding
- 29.13M
- Next earnings
- Nov 16, 2026
52-week range
ENTA stock today
Shares of Enanta Pharmaceuticals (ENTA) finished higher on Oct 7 at $12.37, a gain of 1.64% or $0.20 per share, versus the S&P 500's 0.22% decline. At this level, ENTA sits in the middle of its 52-week range of $10.20 to $17.15: 27.9% below the high and 21.3% above the low. Enanta Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$2.42), so its P/E ratio is not meaningful.
Enanta Pharmaceuticals's next earnings report is expected on Nov 16, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Enanta Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2013
Earnings
Earnings history- Next report
- Nov 16, 2026
Enanta Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RLMDRelmada Therapeutics Inc. | 3.25 | -0.91% | $346.68M | vs ENTA |
| EBSEmergent BioSolutions Inc. | 7.07 | +1.73% | $362.50M | vs ENTA |
| ARCTArcturus Therapeutics Holdings Inc. | 12.77 | -1.81% | $362.82M | vs ENTA |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.72% | $365.08M | vs ENTA |
| IRDOpus Genetics Inc. | 4.41 | +0.68% | $366.89M | vs ENTA |
| TTRXTurn Therapeutics Inc. | 12.10 | +3.95% | $367.45M | vs ENTA |
| CYPHCypherpunk Technologies Inc. | 3.05 | -6.44% | $328.68M | vs ENTA |
| BNTCBenitec Biopharma Inc. | 8.99 | -0.11% | $313.60M | vs ENTA |
Indexes, lists and sector
Largest Health Care stocks
Enanta Pharmaceuticals stock FAQ
What is Enanta Pharmaceuticals's stock price today?
ENTA last traded at $12.37 as of Oct 7, 4:00 PM EDT, up 1.64% on the day. Prices are delayed at least 15 minutes.
When is Enanta Pharmaceuticals's next earnings date?
Enanta Pharmaceuticals is expected to report earnings on Monday, November 16, 2026.
What is the ENTA 52-week high?
The 52-week high for ENTA is $17.15 and the 52-week low is $10.20. The stock is currently 27.9% below its high.